Search results
15 paź 2021 · An alternative to brachytherapy-based PBI (which is an invasive procedure) is PBI delivered using external beam radiation.
23 cze 2022 · Radiotherapy after breast-conserving surgery (BCS) is indicated in ductal carcinoma in situ (stage 0), as RT decreases the risk of local recurrence (LR) by 50–60%. In early stage (stage I-II) invasive breast cancer RT remains a standard treatment following BCS.
This is the first European consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer, including moderate and ultrahypofractionated regimens for whole breast, chest wall, nodal, and partial breast irradiation.
This review will give an overview of the benefits of radiotherapy (RT) for breast cancer, including a discussion of RT in the postmastectomy and in the breast-conserving therapy (BCT) settings. Various treatment delivery strategies and their respective benefits and drawbacks are presented.
18 mar 2023 · Multifleaf collimators allow for precise beam shaping and minimization of lung and heart exposure. Dose homogeneity techniques include field in field and electronic compensation. Proton beam radiation therapy is being actively studied to further optimize normal organ avoidance in the setting of RNI.
13 kwi 2021 · Intraoperative radiotherapy with electrons (IOERT) boost could be not inferior to external beam radiotherapy (EBRT) boost in terms of local control and tissue tolerance.
15 paź 2021 · Radiation therapy (RT) is an essential component in the management of breast cancer. Following breast-conserving surgery (BCS), adjuvant RT is the standard of care for most patients. Traditionally, RT was delivered with standard whole breast irradiation (WBI) over 5-7 weeks following BCS.
